AIVITA Biomedical CEO Hans Keirstead, Ph.D. to Speak at Stem Cell Cures Consortium Conference
IRVINE, Calif. – June 7, 2017 – AIVITA Biomedical today announced that Chief Executive Officer Hans Keirstead, Ph.D. will be…
AIVITA Appoints Operations and Customer Care Executive Ed Inal as Chief Operating Officer
IRVINE, Calif. – May 3, 2017– AIVITA Biomedical today announced the appointment of operations executive Ed Inal as Chief…
AIVITA Biomedical to Feature Skin Care Technology at Upcoming Music City SCALE Symposium
IRVINE, Calif. – May 2, 2017 – AIVITA Biomedical today announced that it will be appearing at the upcoming Music…
AIVITA Biomedical CEO Hans Keirstead, Ph.D. to Present as Distinguished Speaker at Upcoming Stem Cell Summit 2017
IRVINE, Calif. – April 3, 2017 – AIVITA Biomedical today announced that Chief Executive Officer Hans Keirstead, Ph.D. will be…
AIVITA Biomedical to Present Skin Care Technology and Products at 15th Annual South Beach Symposium
IRVINE, Calif. – February 7, 2017 – AIVITA Biomedical today announced it will present details of its patented skin…
AIVITA Biomedical Launches PROVOQUE Eye Complex
IRVINE, Calif. – February 2, 2017 – AIVITA Biomedical today announced the launch of PROVOQUETM Eye Complex, a patented…
AIVITA Biomedical Awarded NIH R01 Grant for Development of 3D-Transplantable ‘Retinas’
IRVINE, Calif. – September 29, 2016 – AIVITA Biomedical, a stem cell company with clinical and commercial programs, today…
AIVITA Highlights Ovarian Cancer Therapy at Cancer Stem Cell Conference 2016
IRVINE, Calif. – September 20, 2016 – AIVITA Biomedical today announced that it will present details on its autologous cancer immunotherapy,…
AIVITA CEO Comments on Recent Milestone Achievements in Asterias’ SCiStar Trial for Spinal Cord Injury
IRVINE, C.A., September 13, 2016 – AIVITA CEO and neuroscientist Dr. Hans Keirstead offered his congratulations today for milestones…
AIVITA Biomedical Awarded CIRM Grant for Development of 3D-Transplantable ‘Retinas’
IRVINE, C.A., July 7, 2016 – AiVita Biomedical, a Southern California-based therapeutic development company, today announced that the California…